Source: Business Wire

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

Founder & CEO

Andrew Adamovich

CEO Approval Rating

90/100

AdvanCell is an Australia-based radiopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer.

AdvanCell received $112M in Series C Funding